within Pharmacolibrary.Drugs.ATC.A;

model A02BA07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.8 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ranitidine bismuth citrate is a combination drug containing ranitidine, a histamine H2 receptor antagonist, and bismuth citrate, used for the treatment of peptic ulcers and Helicobacter pylori infections. It was widely used for gastrointestinal disorders but is no longer approved in many countries due to the withdrawal of ranitidine-containing products (linked to NDMA contamination).</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for a typical healthy adult after a single oral dose, in the absence of detailed existing PK studies specifically for the ranitidine bismuth citrate formulation.</p><h4>References</h4><ol><li><p>Lacey, LF, et al., &amp; Smith, JT (1994). Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB). <i>European journal of clinical pharmacology</i> 47(2) 177–180. DOI:<a href=&quot;https://doi.org/10.1007/BF00194969&quot;>10.1007/BF00194969</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7859806/&quot;>https://pubmed.ncbi.nlm.nih.gov/7859806</a></p></li><li><p>Koch, KM, et al., &amp; Davis, IM (1996). Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate. <i>British journal of clinical pharmacology</i> 42(2) 207–211. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2125.1996.39310.x&quot;>10.1046/j.1365-2125.1996.39310.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8864319/&quot;>https://pubmed.ncbi.nlm.nih.gov/8864319</a></p></li><li><p>Koch, KM, et al., &amp; Yin, Y (1996). Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate. <i>British journal of clinical pharmacology</i> 42(2) 201–205. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2125.1996.03929.x&quot;>10.1046/j.1365-2125.1996.03929.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8864318/&quot;>https://pubmed.ncbi.nlm.nih.gov/8864318</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A02BA07;
